1662.6000 -4.10 (-0.25%)
NSE Apr 17, 2025 15:31 PM
Volume: 135.1K
 

1662.60
-0.25%
ICICI Securities Limited
Metropolis’ Q1FY24 revenue growth (-1%) and EBITDA margin (-180bps) were impacted by discontinuation of a PPP contract (Q1FY23 sales of INR 200mn) while the core business grew 12% YoY. Metropolis remains committed to expand its network by: 1) deepening its presence in existing cities and venturing into newer ones, 2) connecting directly with consumers to increase B2C share, 3) M&As to improvise scale and restore margins to pre-covid levels.
Metropolis Healthcare Ltd. is trading below its 100 day SMA of 1834.4
More from Metropolis Healthcare Ltd.
Recommended